FEATURED SESSIONS

This event will feature two new sessions on late-breaking trials:

• LAAOS-III: LA Appendage Closure with Concomitant Surgery
• The Converge Trial: Hybrid Minimally Invasive Surgery and Catheter Ablation for Long Standing Persistent AF

This continuing medical educational initiative provides two full days of presentations and interactive live activity developed and delivered by internationally recognized thought leaders in the field of atrial fibrillation. We will be using a hybrid format this year hosting attendees in person along with providing a virtual platform to allow attendance for those that wish to join virtually. This year’s agenda will again consist of plenary lectures, plenary debates, and live panel discussions. There will also be concurrent breakout sessions under two tracks - Electrophysiology and Cardiac Surgery.

 EDUCATIONAL OBJECTIVES

• Discuss the electrophysiology of atrial fibrillation.
• Cite the newest concepts of atrial electrophysiology, including differences in endocardial and epicardial conduction patterns and how they can impact the interpretation of electrophysiologic mapping.
• Identify the advantages and limitations of activation-time mapping, voltage mapping, and phase mapping for the analysis of the electrophysiology of atrial fibrillation.
• Demonstrate improved outcomes for the catheter ablation of atrial fibrillation using the most advanced techniques.
• Demonstrate improved outcomes for the surgical ablation of atrial fibrillation using the most advanced techniques.
• Discuss the electrophysiological basis of catheter ablation for paroxysmal and nonparoxysmal atrial fibrillation.
• Cite the current indications for catheter ablation of atrial fibrillation in paroxysmal and non-paroxysmal atrial fibrillation.
• Explain the current results of catheter and surgical ablation for paroxysmal and non-paroxysmal atrial fibrillation.
• Implement a safe and effective left atrial appendage closure program using current percutaneous and surgical techniques to reduce the risk of stroke in patients with atrial fibrillation.
• Determine the limitations of the HRS definitions of success and failure for the interventional (catheter and surgical) treatment of atrial fibrillation.
• Examine the differences in the electrophysiology of primary (“stand-alone”) and secondary (“concomitant”) atrial fibrillation.
• Discuss the electrophysiological basis of concomitant surgical ablation for atrial fibrillation in patients undergoing valve surgery with or without coronary artery disease.
• Review the surgical options for the treatment of atrial fibrillation in patients undergoing mitral valve, aortic valve, and/or coronary artery bypass surgery.
• Restate the currently recommended surgical lesion patterns for the concomitant surgical treatment of atrial fibrillation in patients undergoing mitral valve, aortic valve, and/or coronary artery bypass surgery based on recent clinical trial results.
• Improve the outcomes of patients undergoing catheter and surgical therapies for atrial fibrillation using lifestyle modifications targeting obesity and other risk factors.

TARGETED AUDIENCE

This CME program has been designed to meet the educational needs of Cardiologists, Electrophysiologists, Cardiac Surgeons, Internists, Cardiology Trainees, Cardiac Surgery Trainees, Physician Assistants, Nurse Practitioners, Nurses and any other health care professionals who participate in the care of atrial fibrillation.

ACCREDITATION

The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 15.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

To find out more please visit the official event page.